Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
alemtuzumab
algorithm
amyloid angiopathy, cerebral
angiitis, granulomatous of CNS
angiitis, isolated of CNS
anti DNA agent
anti JC virus antibodies
antibiotics
antiviral agents
asymptomatic
ataxia
atypical
B 12 deficiency
bacterial infection
Behcet's syndrome
biologic markers
brain biopsy
brain biopsy, false negative
brain biopsy, negative
brainstem, lesion of
brentuximab
brucellosis, nervous system involvement with
Brudzinski's sign
carbon monoxide poisoning
carcinoma
CAT scan, abnormal
CAT scan, emission, abnormal
CD4 counts
central nervous system, infection of
central pontine myelinolysis
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar lesion
cerebellum, disease of
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, gammaglobulin of
cerebrovascular accident, secondary prevention
chemotherapy, CNS treatment and complications with
cladribine
Clinical Pathologic Conference(C.P.C.)
coinfection
Collier's sign
complications
controversies in neurology
cortical blindness
cranial neuropathy
cytosine arabinoside
daclizumab
delay in diagnosis
demyelinating disease
dermatomyositis
disability, neurological
drug abuse
drug holiday
drug induced neurologic disorders
drug withdrawal
dysarthria
efalizumab
efficacy
electroencephalogram, abnormalities of
electron microscopy
encephalitis
encephalitis, brainstem
encephalitis, human immunodeficiency virus type 1
encephalitis, paraneoplastic
encephalitis, viral
epidemiology of neurology
Epstein-Barr virus
etanercept
evidence-based research
false negative
fever
fingolimod
gadolinium
gammaglobulin therapy, intravenous
gaze palsy, vertical
gliomatosis cerebri
Guillain Barre syndrome
hearing loss
hemiparesis
hemiplegia, progressive
hepatosplenomegaly
highly active antiretroviral therapy
Hodgkin's disease
human immunodeficiency virus type 1
hydrocephalus
hypercalcemia
hypertensive encephalopathy
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune reconstitution inflammatory syndrome
immune-related adverse events
immunocompetent
immunofluorescent exam of CSF cells
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
in situ hybridization
inclusion bodies
infection
infliximab
interferon
interferon beta 1-a
iododeoxyuridine
JC virus
JC virus cerebellar granule cell neuronopathy
JC virus encephalopathy
Kernig's sign
leukemia
leukemia, neurologic findings assoc.with
leukoencephalopathy
leukoencephalopathy, differential diagnosis
leukoencephalopathy, toxic
levamisole
level of consciousness, decreased
life expectancy
limbic encephalitis
listeriosis, CNS
lymph node biopsy
lymphadenopathy
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
meningismus
meningitis
midbrain
midbrain, lesion of
middle cerebellar peduncle
middle cerebellar peduncle, lesion
migraine
mitochondrial disease
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, diffusion weighted
MRI, magnetization transfer sequence
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRS
multiple sclerosis
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, relapsing
multiple sclerosis, treatment of
myoclonus
natalizumab
negative
neoplasm, primary of CNS
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic signs
neurologic symptoms
neuromyelitis optica (Devic's disease)
neuropathology
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, peripheral, treatment
nivolumab
ocrelizumab
Ommaya reservoir
opportunistic infection
opportunistic infection, CNS
papovavirus
pembrolizumab
phenylketonuria
plasmapheresis
plasmapheresis, complications of
pleocytosis of cerebrospinal fluid
polymerase chain reaction
polymerase chain reaction, false negative
polymyositis
polyneuropathy, chronic inflammatory demyelinating
posterior leukoencephalopathy syndrome
practice guidelines
preclinical
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psoriasis
quality of life
radiation therapy, CNS treatment and complications with
remote effect of cancer on the nervous system
review article
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
risk factors
risk stratification
risk-benefit assessment
rituximab
safety
sarcoidosis
sarcoidosis, CNS
screening
serologic testing
seropositive
slow virus infection of CNS
steroid therapy, CNS treatment and complications with
symmetric brain lesions
systemic lupus erythematosus
treatment of neurologic disorder
tuberculosis
tumor necrosis factor inhibitor
upgaze
vaccination, neurologic complications with
vaccine
vasculitides
vasculopathy
vincristine neurotoxicity
viral infection
viral infection, CNS
weakness, progressive
Whipple's disease
white matter disease
workup
Showing articles 300 to 350 of 3117 << Previous Next >>

Clinicopathological Conference, Glutamic Acid Decarborylase 65 Autoantibody-Associated Stiff-Person Syndrome
NEJM 390:1712-1719, Case 14-2024, 2024

Recurrent Rhombencephalitis Associatedwith Anti-GAD65 Antibody
Neurol 102:e208040, Alferes,A.R.,et al, 2024

Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024

Clinicopathologic Conference, Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis
NEJM 390:843-851, Case 7-2024, 2024

Fluorodeoxyglucose PET/CT as Possible Early Diagnostic Tool Preceding MRI Changes in Borna Disease Virus 1 Encephalitis
Lancet 403:665-666, Bayas, A., et al, 2024

Diagnosis and Management of ANCA-Associated Vasculitis
Lancet 403:683-698, Kronbichler, A., et al, 2024

Lecanemab for Alzheimer Disease, Is It Worth It?
Neurol 102:e209265, Nelson,S.E. & Lopez,O.L., 2024

Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024

Anti-NMDA Receptor Encephalitis Presenting with Cerebellitis in a Pediatric Patient
Neurol 102:e209259, Moehlman,M. & Kornbluh,A.B., 2024

Leptomeningitis with Communicating Hydrocephalus in an Immunocompromised Patient with Disseminated Sporotrichosis
Neurol 103:e209586, Taborda,M.H.,et al, 2024

Expanding Clinical Spectrum an Anti-GQ1b Antibody Syndrome, A Review
JAMA Neurol 81:762-770, Lee,S-U.,et al, 2024

MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis:A Systematic Review and Meta-Analysis
AJNR 45:977-986, Almeida,F.C.,et al, 2024

Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024

Clinicopathologic Conference, Paraneoplastic Encephalomyelitis Due to Small-Cell Lung Carcinoma and Concurrent Cerebral Amyloid Angiopathy
NEJM< 391357-369, Case 23-2024, 2024

Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and Children
Neurol 103:e209321, Varley,J.A.,et al, 2024

Clinical Presentation, Management, and Outcome in Neurolymphomatosis, A Systematic Review
Neurol 103:e209698, Kaulen.L.D.,et al, 2024

An Unusual Etiology of Lumbosacral Plexopathy in a Patient with HIV
Neurol 103:e209930, Madduluri,B.,et al, 2024

Clinicopathologic Conference, Myasthenia Gravis
NEJM 391:1441-1450, Case 32-2024, 2024

Powassan Virus Encephalitis: A Tertiary Center Experience
Clin Inf Dis 78:80-89, Mendoza,M.A.,et al, 2024

"Panda Sign" in West Nile Encephalitis
Neurol 103:e209985, Watson,C.C.,et al, 2024

Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology
Ann Neurol 96:1020-1025, Falso,S.,et al, 2024

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024

Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024

Amyloid-Related Imaging Abnormalities:An Update
AJR 220:562-575, Roytman,M.,et al, 2023

Overlapping Anti-NMDAR Encephalitis and Multiple Sclerosis: A Case Report and Literature Review
Front Immunol doi:10.3389/Fimmun.2023.1088801, Liu,P.,et al, 2023

Monkeypox-Associated Central Nervous System Disease:A Case Series and Review
Ann Neurol 93:893-905, Money,K.M.,et al, 2023

Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023

Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Ann Neurol 93:297-302, Valencia-Sanchez,C., et al, 2023

Autoimmune Encephalitis Misdiagnosis in Adults
JAMA Neurol 80:30-39, Flanagan,E.P.,et al, 2023

A 67-Year-Old Woman with Progressive Tingling Sensations and Imlalance
Neurol 100:151-157, Horta,L.F.B.,et al, 2023

Differentiating Multiple Sclerosis from AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease with Imaging
Neurol 100:e308-e323, Cortesa,R.,et al, 2023

Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir
Ann Neurol 93:88-102, Grundmann,A.,et al, 2023

Rapidly Progressive Dementia in a Man With HIV Infection and Undetectable Plasma Viral Load
Neurol 100:344-348, Chishimba,L.C.,et al, 2023

Occult Breast Cancer with Anti-Ri Antibody Positivity and Pontine Hot Cross Bun Sign
JAMA Neurol 80:207-208, Liu,Y.,et al, 2023

Impacts of Climate Change and Air Pollution on Neurologic Health, Disease, and Practice, A Scoping Review
Neurol 100:474-483, Louis,S.,et al, 2023

Long-Term Outcomes of Bariatric Surgery in Idiopathic Intracranial Hypertension Patients
Neurologist 28:87-93, Hermes,S.M.,et al, 2023

Should We Test for IgG Antibodies Against MOG in Both Serum and CSF in Patients with Suspected MOGAD?
Neurol 100:497-498, Kim,H.J. & Palace, J., 2023

Glucose Hypermetabolism in the Basal Ganglia
Neurol 101:90-91, Kim,Y.E.,et al, 2023

MR Imaging Findings in a Large Population of Autoimmune Encephalitis
AJNR 44:799-806, Gillon,S.,et al, 2023

An 82-Year-Old Woman with Subacute Ophthalmoparesis and Ataxia
Neurol 101:e570-e575, Rodrigo-Gisbert,M.,et al, 2023

Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023

Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023

NSAIDS, Hormonal Contraception, and Venous Thromboembolism, A Harmful Drug Interaction That Deserves More Attention
BMJ 382:p1990, Schmidt,M., 2023

Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD):Clinical Features and Diagnosis
www.UptoDate.com, Sept, Flanagan,E.P. & Tillema,J-M, 2023

MR Imaging Patterns and Prognosis in Powassan Virus Encephalitis
Neurologist doi.10.1097/NRI.0000000000000533, Finelli,P.F., 2023

Polymyalgia Rheumatica
Lancet 402:1459-1472, Espigol-Frigole,G.,et al, 2023

Surgical Decompression for Malignant Cerebral Edema After Ischemic Stroke:Cochrane Review
Stroke 54:e500-5502, Dower,A.,et al, 2023

CHANTER Syndrome
Neurol 101:e2338-e2339, Rizkallah,B. & Rubin,D.B., 2023



Showing articles 300 to 350 of 3117 << Previous Next >>